BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1063 related articles for article (PubMed ID: 23614720)

  • 1. The cell biology of prion-like spread of protein aggregates: mechanisms and implication in neurodegeneration.
    Costanzo M; Zurzolo C
    Biochem J; 2013 May; 452(1):1-17. PubMed ID: 23614720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalization of the prion hypothesis to other neurodegenerative diseases: an imperfect fit.
    Guest WC; Silverman JM; Pokrishevsky E; O'Neill MA; Grad LI; Cashman NR
    J Toxicol Environ Health A; 2011; 74(22-24):1433-59. PubMed ID: 22043906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic prions and other human neurodegenerative proteinopathies.
    Le NT; Narkiewicz J; Aulić S; Salzano G; Tran HT; Scaini D; Moda F; Giachin G; Legname G
    Virus Res; 2015 Sep; 207():25-37. PubMed ID: 25449570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloids, prions and the inherent infectious nature of misfolded protein aggregates.
    Soto C; Estrada L; Castilla J
    Trends Biochem Sci; 2006 Mar; 31(3):150-5. PubMed ID: 16473510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-seeding of prions by aggregated α-synuclein leads to transmissible spongiform encephalopathy.
    Katorcha E; Makarava N; Lee YJ; Lindberg I; Monteiro MJ; Kovacs GG; Baskakov IV
    PLoS Pathog; 2017 Aug; 13(8):e1006563. PubMed ID: 28797122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
    Victoria GS; Zurzolo C
    J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prion-like aggregates: infectious agents in human disease.
    Westermark GT; Westermark P
    Trends Mol Med; 2010 Nov; 16(11):501-7. PubMed ID: 20870462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The propagation of prion-like protein inclusions in neurodegenerative diseases.
    Goedert M; Clavaguera F; Tolnay M
    Trends Neurosci; 2010 Jul; 33(7):317-25. PubMed ID: 20493564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion, prionoids and infectious amyloid.
    Liberski PP
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S80-4. PubMed ID: 24262195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion and prion-like diseases in animals.
    Aguilar-Calvo P; García C; Espinosa JC; Andreoletti O; Torres JM
    Virus Res; 2015 Sep; 207():82-93. PubMed ID: 25444937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective and neurotoxic signaling by the prion protein.
    Resenberger UK; Winklhofer KF; Tatzelt J
    Top Curr Chem; 2011; 305():101-19. PubMed ID: 21598098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcellular spread of cytosolic amyloids, prions, and prionoids.
    Aguzzi A; Rajendran L
    Neuron; 2009 Dec; 64(6):783-90. PubMed ID: 20064386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein misfolding and prion diseases.
    Cohen FE
    J Mol Biol; 1999 Oct; 293(2):313-20. PubMed ID: 10550211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion-Like Characteristics of Polyglutamine-Containing Proteins.
    Pearce MMP; Kopito RR
    Cold Spring Harb Perspect Med; 2018 Feb; 8(2):. PubMed ID: 28096245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.